Diabetes Technology & Therapeutics
Editor-in-Chief: Satish K. Garg, MD
Latest Impact Factor* is 2.698
*2016 Journal Citation Reports® (Clarivate Analytics, 2017)
The only peer-reviewed journal covering all aspects of diagnosing and managing diabetes with cutting-edge devices, drugs, drug delivery systems, and software.View Aims & Scope…
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.